These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [New trends in the treatment of hemodynamic disorders in liver cirrhosis]. Vorob'ev LP; Maev IV Klin Med (Mosk); 1991 Sep; 69(9):11-4. PubMed ID: 1687073 [TBL] [Abstract][Full Text] [Related]
7. Doppler evaluation of the effects of pharmacological treatment of portal hypertension. Piscaglia F; Gaiani S; Donati G; Masi L; Bolondi L Ultrasound Med Biol; 1999 Jul; 25(6):923-32. PubMed ID: 10461720 [TBL] [Abstract][Full Text] [Related]
8. Clonidine for portal hypertension: a sympathetic solution? Blendis LM Ann Intern Med; 1992 Mar; 116(6):515-7. PubMed ID: 1739244 [No Abstract] [Full Text] [Related]
9. [Portal hypertension in the absence of liver cirrhosis and hepatic obstruction of the main vessels of the portal system (arteriovenous insufficiency of portal circulation)]. Patsiora MD; Ershov IuA Khirurgiia (Mosk); 1980 Jan; (1):64-9. PubMed ID: 7392493 [No Abstract] [Full Text] [Related]
10. The pharmacological therapy of portal hypertension. Groszmann RJ; Atterbury CE Adv Intern Med; 1986; 31():341-58. PubMed ID: 2868621 [No Abstract] [Full Text] [Related]
11. [Physiopathology of portal hypertension in liver cirrhosis]. Cervela LA Rev Esp Enferm Apar Dig; 1973 Jan; 39(2):223-38. PubMed ID: 4690385 [No Abstract] [Full Text] [Related]
12. Extrahepatic portal venous hypertension in adults. Sherlock S Clin Gastroenterol; 1985 Jan; 14(1):1-19. PubMed ID: 3886211 [No Abstract] [Full Text] [Related]
13. Effects of ondansetron on portal hemodynamics in liver cirrhosis. Tripkovic M; Kozjek F; Krizman I; Jereb J; Francetic I; Grabnar I; Mrhar A Int J Clin Pharmacol Ther; 2000 Sep; 38(9):436-40. PubMed ID: 11020031 [TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and portal-systemic collaterals in portal hypertension. Gana JC; Serrano CA; Ling SC Ann Hepatol; 2016; 15(3):303-13. PubMed ID: 27049484 [TBL] [Abstract][Full Text] [Related]
16. Liver disease in cystic fibrosis presents as non-cirrhotic portal hypertension. Witters P; Libbrecht L; Roskams T; De Boeck K; Dupont L; Proesmans M; Vermeulen F; Maleux G; Monbaliu D; Pirenne J; Cassiman D J Cyst Fibros; 2017 Sep; 16(5):e11-e13. PubMed ID: 28347603 [No Abstract] [Full Text] [Related]
17. [Portal hypertension in the absence of liver cirrhosis and extrahepatic circulatory blockade]. Bykov VS Klin Med (Mosk); 1981 Oct; 59(10):22-6. PubMed ID: 7031355 [No Abstract] [Full Text] [Related]
18. [Liver structure and function and portal hemodynamics in children with extrahepatic portal hypertension undergoing a portosystemic shunt]. Seniakovich VM; Leont'ev AF; Klochkov SA; Potapov AS Vestn Khir Im I I Grek; 1993; 150(1-2):62-6. PubMed ID: 7701706 [No Abstract] [Full Text] [Related]
19. Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension. Navasa M; Bosch J; Reichen J; Bru C; Mastai R; Zysset T; Silva G; Chesta J; Rodés J Hepatology; 1988; 8(4):850-4. PubMed ID: 3391511 [TBL] [Abstract][Full Text] [Related]